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Cmr1/WDR76 deﬁnes a nuclear genotoxic stress
body linking genome integrity and protein quality
control
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DNA replication stress is a source of genomic instability. Here we identify changed mutation
rate 1 (Cmr1) as a factor involved in the response to DNA replication stress in Saccharomyces
cerevisiae and show that Cmr1—together with Mrc1/Claspin, Pph3, the chaperonin containing
TCP1 (CCT) and 25 other proteins—deﬁne a novel intranuclear quality control compartment
(INQ) that sequesters misfolded, ubiquitylated and sumoylated proteins in response to
genotoxic stress. The diversity of proteins that localize to INQ indicates that other biological
processes such as cell cycle progression, chromatin and mitotic spindle organization may also
be regulated through INQ. Similar to Cmr1, its human orthologue WDR76 responds to
proteasome inhibition and DNA damage by relocalizing to nuclear foci and physically
associating with CCT, suggesting an evolutionarily conserved biological function. We propose
that Cmr1/WDR76 plays a role in the recovery from genotoxic stress through regulation of
the turnover of sumoylated and phosphorylated proteins.
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F
aithful completion of DNA replication is essential for cell
survival and for inheritance of the genetic information.
Replication fork stalling at DNA lesions leads to activation
of the replication checkpoint, which in S. cerevisiae relies on the
recruitment of the checkpoint kinase Mec1/ATR to RPA
(replication protein A)-coated single-stranded DNA, arising from
the uncoupling of the polymerase and the mini-chromosome
maintenance (MCM) helicase1. Mec1-dependent phosphorylation
of the checkpoint mediator Mrc1/Claspin leads to the recruitment
and activation of the effector kinase Rad53 (refs 2,3). The
replication checkpoint induces posttranslational modiﬁcation of
the clamp loader PCNA (proliferating cell nuclear antigen),
promoting the repair or bypass of the lesion4. Failure to activate
the replication checkpoint leads to severe chromosomal
instability, a major trigger for cancer in humans5.
Resumption of DNA replication after checkpoint activation
relies both on the repair or bypass of the lesion and on the
inactivation of checkpoint signalling. The latter requires depho-
sphorylation of Rad53 by the PP4 phosphatase Pph3-Psy2-Psy4
(ref. 6) and proteasome-dependent degradation of fork-associated
factors such as Mrc1 (ref. 7). Speciﬁcally, Mrc1 has recently been
identiﬁed as a target of the ubiquitin ligase complex SCF–Dia2
(ref. 7). Dia2 directly binds Mrc1 and promotes its ubiquitylation
and proteasomal degradation in response to replication stress.
This recovery pathway appears to act in parallel with
dephosphorylation of Rad53, as DIA2 and PPH3 show negative
genetic interaction in the presence of replication stress8.
Cmr1 (changed mutation rate 1) is a nuclear WD40 protein of
unknown function9,10, which has recently appeared in several
large-scale studies. First, Cmr1 was described as a histone-related
protein11, with DNA-binding capacity in vitro and with the
ability to accumulate on chromatin in response to ultraviolet
irradiation12. Furthermore, in a genome-wide screen Cmr1 was
found to speciﬁcally respond to methyl methanesulfonate
(MMS)-induced damage, relocalizing to nuclear foci of
undetermined nature13. Finally, in silico clustering analyses
suggest that CMR1 is co-expressed with genes involved in
processes related to DNA metabolism14. Taken together, these
data suggest a role for Cmr1 in genome maintenance. Here we
identify Cmr1 in two independent screens and provide the ﬁrst
extensive functional characterization of Cmr1 and the nuclear
structure that it forms in response to replication stress and
proteasome inhibition. Together with the replication checkpoint
proteins Mrc1, Pph3 and 25 other proteins, Cmr1 deﬁnes a novel
intranuclear quality control compartment (INQ) for the
sequestering of phosphorylated, sumoylated and ubiquitylated
proteins. Our ﬁndings document a novel connection between the
cellular response to DNA replication stress and turnover of
replication stress factors.
Results
Identiﬁcation of Cmr1 as a genome maintenance factor. In an
effort to identify new factors involved in the maintenance of
genome stability, a series of stable isotope labelling by amino
acids in cell culture (SILAC)-based mass spectrometry (MS)
experiments were performed under conditions wherein the
replication protein Rfa1 and the recombination protein Rad52
were induced to relocalize to DNA repair foci by DNA damage
before protein extraction and pull down using a yellow ﬂuor-
escent protein (YFP) tag (Fig. 1a). This approach identiﬁed a
collection of proteins, including the WD40-domain protein Cmr1
(Fig. 1b). Further, the physical association between Cmr1 and the
RPA complex, which has been reported in several independent
large-scale studies11,15,16, was conﬁrmed by reverse pull down
using Cmr1-YFP as the bait (Fig. 1c and Supplementary Data 1).
In an independent systematic genome-wide screen for mutants
that change mutation rates, we found that cmr1D suppressed the
otherwise elevated mutation rates resulting from expression of
the human mismatch repair (MMR) gene MLH1 (hMLH1) in
S. cerevisiae (Supplementary Fig. 1)17. Further analyses to assess
the involvement of Cmr1 in MMR showed that deletion of CMR1
increases frameshift mutation rates in an MRC1- and MLH1-
dependent manner, but additively increases the overall CAN1
forward mutation rate in conjunction with msh2D and mlh1D
(Table 1a,b). These ﬁndings indicate a defect in replication rather
than in MMR per se.
Cell cycle-independent formation of perinuclear Cmr1 foci.
The observation that endogenously tagged Cmr1 relocalized from
diffusely nuclear to a distinct focus on hMLH1 expression in yeast
or after treatment with MMS, ultraviolet irradiation or hydro-
xyurea (HU;Fig. 1d–f), supported our hypothesis of Cmr1 being
recruited to a replication or DNA repair factory. Surprisingly, but
consistent with a recent report13, the Cmr1 focus did not co-
localize with any known nuclear structures such as telomeres
(Cdc13), nuclear pore complex (Nup49), MMR (Pms1), spindle
pole body (Spc110), recombination (Rad52), replication (Pol30
and Rfa1), or the nucleolus (Nop1, data not shown). We therefore
concluded that Cmr1 deﬁnes a novel nuclear compartment that
forms in response to genotoxic stress.
Given the vicinity of Cmr1 foci to the nuclear periphery,
we further examined Cmr1 foci relative to the nuclear membrane
in asynchronously growing and G1-arrested cells. Cmr1 foci
formed with similar efﬁciency in G1 and S/G2 cells, consistently
localized internally to the nuclear envelope (Nup49-CFP), and
disassembled within 90min after ultraviolet irradiation or on
removal of MMS (Fig. 2a–c and Supplementary Fig. 2a,b).
Accumulation into perinuclear foci was also observed for the
endogenous Cmr1 (Supplementary Fig. 2c,d), indicating that its
localization is not an artefact of the YFP tagging. Structurally,
Cmr1 is predicted to consist of a carboxy-terminal WD40 domain
and of an amino-terminal unstructured region. Using plasmids
expressing YFP fusions of the N-terminal domain (NTD) or
the WD40 domain, we found that the WD40 domain was
necessary and sufﬁcient for the re-localization of Cmr1 into foci
(Fig. 2d,e).
Cmr1 marks an intranuclear quality control compartment. To
gain insight into the biological processes represented by Cmr1
foci, we screened a collection of 4800 green ﬂuorescent protein
(GFP)-tagged proteins for co-localization with Cmr1 (ref. 10). We
took advantage of the observation that Cmr1 perinuclear foci
were also induced by proteasome inhibition (MG132;
Supplementary Fig. 2e), to avoid induction of DNA repair
foci13. Strains exhibiting MG132-induced perinuclear foci were
individually re-tested for co-localization with Cmr1-yEmRFP,
yielding a list of 27 proteins that form Cmr1-co-localizing foci in
response to MG132 (Fig. 3a). Eighty-one per cent (22/27) of these
proteins also co-localized with Cmr1 after MMS treatment.
Notably, proteins implicated in chromosome organization,
mitotic cell cycle, spindle organization and dephosphorylation
were overrepresented among these proteins (Supplementary
Fig. 3a–c). The hits included regulators of the S-phase
checkpoint response (Mrc1 and Pph3) and components of the
anaphase-promoting complex (Cdc20, Cdc27 and Apc4),
chaperones (Hsp104 and Apj1) and histone deacetylases (Hos2
and Rpd3)13.
To further characterize the properties of Cmr1 foci, we
screened the collection of 5,200 non-essential gene deletion
mutants18 to determine the genetic requirements for the
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formation of Cmr1 foci in the presence of replication stress, and
to identify gene deletions that would lead to spontaneous
accumulation of Cmr1 foci. Consistent with their induction by
proteasome inhibition, the top-scoring hits for increased
spontaneous Cmr1 foci were mutants involved in proteasomal
degradation of nuclear targets (irc25D, rpn4D, san1D, tom1D and
dia2D) and ubiquitylation of sumoylated proteins (slx5D; Fig. 3b).
This suggests that even in the absence of acute replication stress,
Cmr1 is channelled towards a perinuclear compartment as part
of an ubiquitin-dependent degradation pathway and points to
Cmr1 foci as nuclear sites for protein degradation. To test this
hypothesis further, we monitored the enrichment of the
proteasome subunit Rpn11 at Cmr1 foci. After MG132
treatment, Rpn11 was observed at 13% (11/81) of the Cmr1
foci, indicating that the proteasome has the potential to target
proteins for degradation at the perinuclear structure deﬁned by
Cmr1 (Supplementary Fig. 3d).
The only non-essential genes required for Cmr1 focus
formation were HSP42 and BTN2 (Fig. 3c). Hsp42 is a small
heat shock protein with chaperone activity, which has recently
been found to be essential for organization and sorting of protein
aggregates into deposition sites in yeast19,20. Similarly, Btn2 has
been identiﬁed in a recent study as a crucial regulator of the
cellular protein quality control21. Interestingly, both Hsp42 and
Btn2 have been implicated in the partitioning of misfolded
proteins between two recently identiﬁed protein quality
compartments, the juxtanuclear quality control (JUNQ) and the
cytosolic insoluble protein deposit (IPOD)21–23.
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Figure 1 | Cmr1 associates with RPA-bound chromatin. (a) Representation of the workﬂow used for the SILAC-based identiﬁcation of protein complexes
associated with DNA repair factors. Yeast strains expressing YFP-tagged (IG54-11D and IG46-1B) or untagged (IG45-8A) proteins were cultured in
SILAC media and harvested in log phase after treatment with DNA-damaging agents. Protein complexes from SILAC lysates were afﬁnity puriﬁed
separately with GFP-Trap. Proteins were trypsin proteolysed and peptides were identiﬁed by liquid chromatography (LC)–MS/MS. (b) Identiﬁcation of
Rfa1-YFP and Rad52-YFP interacting proteins. The plots show log(10) SILAC ratios from GFP-tagged bait versus control from forward and reverse
(SILAC label swap) experiments. Dots indicate identiﬁed proteins. Cmr1 is highlighted in red and some of the known interactors for Rfa1 and Rad52
are indicated in black in the respective plots. (c) Identiﬁcation of Cmr1 interacting proteins. Cmr1-YFP (IG71-2B) was used as bait for the pull down;
Cmr1 is highlighted in red; CCT-chaperonin complex subunits and Rfa1 are indicated in black. (d) Cmr1 relocalization into foci. Representative images of
untreated and MMS-treated cells are shown. Arrowheads indicate selected foci. Scale bar, 2 mm. (e) Quantiﬁcation of Cmr1 foci. Cmr1-YFP localization was
examined by ﬂuorescence microscopy in IG66. Cells were grown to exponential phase and imaged after treatment with zeocin (200mgml 1), MMS
(0.05%), CPT (5mgml 1), 4-NQO (0.2mgml 1), HU (200mM), EMS (0.5%) for 2 h, or 1 h after ultraviolet irradiation (25 Jm 2). Error bars represent
95% conﬁdence intervals. Two to 3 replicates of 100–200 cells were analysed for each condition. (f) hMLH1 expression causes accumulation of Cmr1 foci.
Cells expressing Cmr1-YFP (IG66) were transformed with pEH333 for ectopic expression of hMLH1 or with an empty vector (pEH334). Error bars represent
95% conﬁdence intervals. Two to 3 replicates of 100–200 cells were analysed for each strain.
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To assess whether Cmr1 foci coincide with JUNQ, the
localization of the unassembled von Hippel–Lindau (VHL)
tumour suppressor VHL-GFP24 and Cmr1-yEmRFP was
monitored under conditions leading to VHL misfolding and
accumulation into deposition sites22. Indeed, Cmr1 co-localized
with VHL at the nuclear periphery in450% of the cells, but was
never observed at the perivacuolar IPOD (Supplementary Fig. 4a).
As Cmr1 foci resemble JUNQ but are strictly nuclear, we name
this structure intranuclear quality control (INQ). In agreement
with our observation that INQ is a nuclear structure, we observed
that 495% of the nuclear mCherry-VHL foci co-localized with
Cmr1, while none of the juxtanuclear or peripheral cytoplasmic
VHL foci co-localized with Cmr1 (Fig. 3d,e), indicating that INQ
is a nuclear variant of JUNQ that can be distinguished by the
presence of Cmr1. Notably, MG132-induced nuclear VHL foci
only required BTN2, while MMS-induced VHL foci also required
HSP42, indicating that the sorting of Cmr1 and VHL to INQ
could occur by different mechanisms (Supplementary Fig. 4b,c).
The physical interaction of Cmr1 with all eight subunits of the
chaperonin containing TCP1 (CCT) (Fig. 1c) prompted us to
examine the recruitment of CCT to INQ. On expression of Cct6-
YFP, B60% of the cells exhibited one to three cytoplasmic and
nuclear Cct6 foci, typically one very bright focus in the cytoplasm
and one weaker focus at the nuclear periphery (Fig. 3f).
Importantly,B12% of the Cct6-YFP perinuclear foci co-localized
with Cmr1, while no co-localization was observed with the
brighter cytoplasmic focus. Notably, Cmr1 itself did not behave
similar to a misfolded protein, as its relocalization to INQ was not
perturbed by the actin or microtubule depolymerizing drugs
latrunculin B and nocodazole, respectively, a requirement
previously demonstrated for relocalization of misfolded proteins
to JUNQ (Supplementary Fig. 4d,e and data not shown)20,22.
Moreover, the stability of Cmr1 did not change signiﬁcantly after
MMS treatment (Fig. 3g), suggesting that Cmr1 could be a
mediator rather than a target of proteasomal degradation. Taken
together, Cmr1 deﬁnes a novel intranuclear protein quality
control structure, INQ, for proteasome-dependent turnover
and/or refolding of proteins primarily involved in DNA
metabolism and cell cycle control.
Cmr1 interacts with chromatin and replication factors. As
Cmr1 relocalization was not coupled to its degradation, we rea-
soned that Cmr1 might facilitate another aspect of INQ function.
To identify possible targets of Cmr1 function, we performed a
systematic genome-wide screen for in situ physical interactions
using bimolecular ﬂuorescence complementation10 (Fig. 4a).
A query strain expressing Cmr1 fused to the C-terminal
fragment of Venus (Cmr1-VC) was crossed to a library of
5,809 strains expressing proteins fused to the Venus N terminus25
(VN) and physical interactions (VN–VC) were assessed by the
appearance of a Venus ﬂuorescence signal. We found 79 proteins
Table 1 | Effect of Cmr1 on mutation rates and chromosome loss.
a. Mutation rates
Genotype Strain Mutation rate (fold change*)
CanR ( 10 7) Lysþ ( 10 7)
Wild type IG106-4D 3.8 4.5
cmr1D IG106-1C 4.7 (1.2) 16 (4)w
mlh1D IG106-5A 63 (17)w 77420 (17204)w
cmr1D mlh1D IG106-1D 91 (24)w 23790 (5278)w,z
msh2D IG137- 66D 56 (15)w 30950 (6878)w
cmr1D msh2D IG137-28C 338 (89)w,z 43530 (9673)w
mrc1D IG172-7C 16 (4)w 6.2 (1.4)
cmr1D mrc1D IG172-4B 21 (6)w 6.9 (1.5)
b. Replication stress-induced mutation frequencies
Genotype Strain Mutation frequency (fold change*)
CanR ( 10 7) Lysþ ( 10 7)
Wild type IG106-4D 53 40
cmr1D IG106-1C 34 (0.6) 99 (2.5)w
c. Rates of chromosome loss (BiM assay)70
Genotype Strains Chromosome loss ( 10 2) (fold change*) s.d. ( 10 2)
Wild type ML8-9AW4700-10C 3.3 0.5
cmr1D IG79-6DDP1 6.6 (2)w 1.1
rad52D SMG259-3C SMG259-11B 7.5 (2.3)w 1.6
cmr1D rad52D IG162-2D IG184-11C 14.5 (4.5)w,z 3.3
Wild type ML8-9AW4700-10C 0.4 0.09
cmr1D IG79-6DDP1 0.8 (2.1) 0.7
mrc1D IG156-7D IG179-3B 3.1 (7.8)w 0.8
cmr1D mrc1D IG156-9B IG156-9C 1.9 (4.8)w 0.5
BiM, bimaters assay; MMS, methyl methanesulfonate.
(a) Spontaneous mutation rates. Forward (CanR) and frameshift (LYS214A) mutation rates were determined for IG106-4D (wt), IG106-1C (cmr1D), IG106-5A (mlh1D), IG106-1D (cmr1D mlh1D), IG137-66D
(msh2D), IG137-28C (msh2D cmr1D), IG172-7C (mrc1D) and IG172-4B (mrc1D cmr1D). (b) Induced mutation frequencies. Fold change compared with wild type is indicated in parentheses. Replication
stress-induced mutation frequencies were determined after growth in 0.03% MMS for 30min. (c) Rates of chromosome loss (BiM assay). Diploid strains homozygous for the indicated gene deletions
were grown on rich medium and subsequently tested for the ability to mate with a MATa tester strain (R113). Frequency of mating, derived from loss of the endogenous MATa locus, is used as a measure
of chromosomal instability. The two sets of BiM assays were performed with different batches of media; s.d. of the rate is reported.
*Relative to wild type.
wSigniﬁcant (Po0.05) compared with wild type.
zSigniﬁcant (Po0.05) difference between single and double mutant.
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to be unique interactors of Cmr1 compared with other bait
proteins tested (Supplementary Table 1 and unpublished data).
These showed a signiﬁcant overrepresentation of Gene Onthology
biological process terms related to DNA replication, transcription
and regulation of gene expression (Fig. 4b), consistent with the
notion that Cmr1 is a component of chromatin11,12. However,
none of the other INQ factors were found to interact with Cmr1.
The VN–VC interaction signals were mainly nuclear and a
subnuclear localization pattern into foci or speckles was often
observed (Supplementary Fig. 5). Interestingly, four replication
fork proteins, Mcm3, Pri1, Rfc2 and Rfc3, were identiﬁed in this
screen (Fig. 4c,d and Supplementary Fig. 5). Notably, the Mcm3-
Cmr1 interaction signiﬁcantly increased by about twofold in
response to MMS treatment (Fig. 4d). Taken together, this
analysis conﬁrms that Cmr1 interactions are enriched for
chromatin-associated factors11,12.
Btn2 promotes Mrc1 turnover and relocalization to INQ.
Given the interaction of Cmr1 with replication fork components,
and based on our observation that the replication checkpoint
mediator Mrc1 localizes at INQ (Fig. 3a), we further addressed
the functional relationship between Cmr1 and Mrc1. Mrc1-CFP
formed foci in response to DNA-damaging agents with a nearly
identical proﬁle to that of Cmr1-YFP (Supplementary Fig. 6a),
and the two proteins mostly co-localized after MMS or MG132
treatment (Fig. 5a,b). Nevertheless, the ability of Cmr1 or Mrc1 to
form foci occurred independently of each other (Supplementary
Fig. 6b,c).
Following replication checkpoint activation, Mrc1 is phos-
phorylated at (S/T)Q sites2, which stimulates its degradation via
Dia2 and possibly other factors, to promote recovery from
replication stress8. To establish whether there is a correlation
between the degradation of Mrc1 and its relocalization to INQ,
we took advantage of the replication-proﬁcient but checkpoint-
defective separation-of-function mutant mrc1AQ2. The mrc1AQ
mutant showed constitutively higher levels of Mrc1 protein due to
a partial defect in Dia2-mediated degradation (Fig. 5c,d)8. After
treatment with MMS, the Mrc1AQ protein was partially defective
in relocalization to INQ (Fig. 5e) and Mrc1 foci were almost
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the percentage of spontaneous Cmr1 foci compared with wild type were manually retested. Only the mutants giving a result signiﬁcantly different from the
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the wild-type reference strain for the manual re-testing. (c) Cmr1 foci are dependent on Hsp42 and Btn2. Cells deleted for BTN2 (IG239-2B) or HSP42
(IG238-9D) and expressing Cmr1-YFP were treated with MMS or MG132 for 2 h. Two to 3 replicates of 100–200 cells were analysed for each condition.
Error bars represent 95% conﬁdence intervals. (d) Cmr1 deﬁnes INQ. Cells expressing Cmr1-YFP (IG66), Cherry-VHL (pESC-mCherry-VHL) and
Nup49-CFP (pNEB21) were grown at 25 C to log phase in synthetic complete medium lacking tryptophan and uracil, and with 2% rafﬁnose as a carbon
source. Cherry-VHL expression was induced by addition of 3% galactose for 3 h, followed by a shift to 37 C and treatment with 75 mgml 1 MG132 in 2%
glucose for 1 h before imaging. Arrowheads mark VHL and Cmr1 foci. Images were deconvolved using the Volocity software (PerkinElmer). Scale bar, 2 mm.
(e) Quantiﬁcation of the foci described in d. Cherry-VHL foci (n¼ 214) located inside and outside the nuclear periphery were assessed for co-localization
with Cmr1-YFP. (f) Cmr1 and the CCT–chaperonin complex co-localize at perinuclear foci. Cells express Cmr1-yEmRFP (IG111), Nup49-CFP (pNEB21) and
Cct6-YFP (pIG20). Orange arrowhead, Cmr1 and Cct6 co-localizing at a perinuclear focus. Yellow arrowhead, Cct6 focus. Scale bar, 2 mm. (g) Cmr1 is not
degraded during the DNA-damage response. G1-arrested cells (IG174) were released into YPD containing 200mgml 1 cycloheximide (CHX) or 0.05%
MMS. After 60min of MMS treatment, CHX and 75 mgml 1 MG132 or CHX and MG132 were added. Cmr1-TAP and tubulin were analysed by
immunoblotting, using cmr1D (DP1) as a negative control. Cmr1 protein levels relative to the sample taken before addition of CHX are indicated below
the blot.
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completely absent in a dia2D mutant (Supplementary Fig. 6d).
Similarly, abolishing INQ through deletion of BTN2 or HSP42
prevented Mrc1 focus formation (Fig. 5f,g) and btn2D led to a
signiﬁcant decrease in the turnover of Mrc1 with or without
replication or proteasomal stress (Fig. 5h,i), as measured using a
ﬂuorescence timer construct, consisting of a fast-maturing GFP
and a slow-maturing mCherry26. Together, these data support a
functional relationship between Mrc1 turnover during replication
stress and relocalization of the protein to INQ.
cmr1D suppresses mutations in MRC1, CTF18 and PPH3. In
parallel to checkpoint mechanisms, several other pathways con-
tribute to replication stress tolerance including homologous
recombination, translesion synthesis, template switching and
replication fork stabilization and restart (reviewed in ref. 27), and
mutants in these pathways display different degrees of sensitivity
to replication stress. The partial redundancy among these
pathways may explain the lack of pronounced MMS, HU and
ultraviolet irradiation sensitivity of the cmr1D mutant (see below
and ref. 12). Hence, to uncover the epistatic relationship between
CMR1 and known replication stress tolerance pathways, we
performed a genome-wide screen for CMR1 genetic interactions
in the presence of replication stress (HU) using the synthetic
genetic array (SGA) approach28. Differential growth on HU-
containing plates between the single and double mutants was
assessed using ScreenMill29 and revealed negative genetic
interactions of CMR1 with genes in the homologous
recombination pathway (RAD50, RAD55 and MMS4), and
suppression of defects associated with deletion of MRC1 and
TOF1 of the replication-pausing checkpoint complex
(Supplementary Tables 2 and 3). Consistently, cmr1D additively
increased spontaneous chromosome loss in a rad52D mutant and
suppressed the high chromosome loss rates of an mrc1D mutant
(Table 1c). Additional manual testing further showed that
deletion of CMR1 was able to suppress the MMS and HU
sensitivity of pph3D (PP4 phosphatase subunit) and ctf18D
(alternative clamp loader) mutants (Fig. 5j). Importantly,
suppression of the MMS sensitivity of the ctf18D mutant by
cmr1D probably reﬂected a suppression of the DNA replication
checkpoint defect but not the cohesion defects associated with
this mutant30–32, as the severe defect in sister chromatid cohesion
in the ctf18Dmutant was not alleviated by cmr1D (Supplementary
Fig. 7b). Notably, hsp42D was epistatic with cmr1D for
suppressing the DNA damage sensitivity of ctf18D, suggesting
that relocalization of Cmr1 to INQ is required for Cmr1 function
in replication stress tolerance (Supplementary Fig. 7a). Consistent
with the increased rate of chromosome loss in the rad52D cmr1D
mutant compared with the single mutants, cmr1D displayed a
negative genetic interaction with both rad52D and mre11D for
survival on MMS (Fig. 5k), indicating a requirement for Cmr1 in
the absence of functional homologous recombination. Given that
no genetic interactions were observed with genes involved in
template switching (rad5D), MMR (msh2D, msh6D and pms1D),
post-replicative repair (rad18D, mms2D and mms22D) or
translesion synthesis (rev3D; Supplementary Fig. 7c–e and
Supplementary Table 2), these data suggest that Cmr1 either
acts as a negative regulator of a factor required for HU resistance
in the absence of Mrc1-Ctf18-Pph3 or promotes a pathway that is
toxic in mutants of Mrc1-Ctf18-Pph3.
Cmr1 promotes DNA-damage checkpoint adaptation. The
negative genetic interaction of cmr1D with mutations in
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homologous recombination genes and the suppression of muta-
tions in DNA damage and replication checkpoint genes could be
due to Cmr1 promoting replication restart or regulating check-
point recovery. To directly assess the involvement of Cmr1 in
replication fork restart, we released cells from a G1 arrest into S
phase in the presence of MMS for 45min and subsequently
monitored completion of DNA synthesis by ﬂow cytometry after
MMS removal. As expected, wild-type cells accumulated in S
phase in the presence of MMS and slowly recovered from the
blockage when the drug was removed (Supplementary Fig. 7f,g).
cmr1D cells were proﬁcient in replication checkpoint activation
and restart of DNA synthesis compared with wild type. In con-
trast, a dia2D pph3D mutant was extremely sensitive to MMS and
severely defective in replication restart after removal of MMS
(Fig. 6a and Supplementary Fig. 7f,g). Notably, cmr1D partially
suppressed the MMS sensitivity of the dia2D pph3D mutant
without suppressing the replication restart defect, indicating that
Cmr1 is not acting directly on replication restart. Moreover, also
btn2D and hsp42D partially suppressed the MMS sensitivity of the
dia2D pph3D mutant, suggesting that the suppression conferred
by cmr1D is functionally related to its accumulation at INQ. As
Pph3 and Dia2 are regulators of the DNA damage and replication
checkpoints, respectively, we sought to test whether the sup-
pression of dia2D pph3D MMS sensitivity by cmr1D is due to a
role of Cmr1 in checkpoint adaptation, a mechanism by which
cells deactivate the checkpoint after prolonged exposure to DNA
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damage33. To assess the impact of Cmr1 and INQ on the DNA
damage checkpoint, we performed a checkpoint adaptation assay
using the cdc13-1 allele, which causes uncapping of telomeres
and DNA-damage checkpoint activation at the restrictive
temperature34. We included in the assay a mutant of the INQ
component Rpd3, which has previously been reported to be
adaptation defective35. After growth at the restrictive temperature
for 24 h, the number of cell bodies was counted. This assay
indicated that cmr1D and, to a lesser extent, rpd3D, btn2D and
hsp42D are adaptation defective (Fig. 6b). In contrast, an exo1D
mutant, which reduces resection of uncapped telomeres, rescued
the cdc13-1 temperature sensitivity as described previously36.
Adaptation has previously been linked to Rad53 activity37. We
therefore examined the electrophoretic mobility shift of
phosphorylated Rad53 in the same adaptation assay. cdc13-1
cells grown at the restrictive temperature for 6 h showed elevated
levels of Rad53 phosphorylation, which is completely abolished in
the wild type at 24 h, when adaptation has occurred37,38.
Strikingly, Rad53 remained partially phosphorylated at the 24 h
time point in the cmr1D, btn2D and hsp42D mutants, which is
consistent with the adaptation defect of these mutants (Fig. 6c).
Taken together, these data indicate that INQ promotes DNA-
damage checkpoint adaptation through attenuation of Rad53
phosphorylation.
Sumoylated proteins localize at INQ. Sumoylation has pre-
viously been implicated in checkpoint regulation39 and a strong
negative genetic interaction of cmr1D was observed with
mutation of the SLX5-SLX8 small ubiquitin-like modiﬁer
(SUMO)-targeted ubiquitin ligase (STUbL; Fig. 6d and
Supplementary Table 2). This raised the possibility that
sumoylation could be a signal for proteins to be channelled to
the proteasome via INQ and Cmr1. This prompted us to examine
the localization of sumoylated proteins in cmr1D and slx8D
mutant cells. Both single mutants exhibited accumulation of
SUMO foci (Fig. 6e), with an additive effect in the slx8D cmr1D
double mutant. The increase in SUMO foci in these mutants
correlated with the accumulation of high-molecular-weight
SUMO-conjugated proteins and this accumulation was more
pronounced in the cmr1D slx8D double mutant (Fig. 6f). Rather
than being due to increased spontaneous genome instability
(Supplementary Fig. 6e), the accumulation of high-molecular-
weight SUMO conjugates in the cmr1Dmutant probably reﬂects a
defect in the turnover of the conjugates themselves. Importantly,
Slx8 and Cmr1 co-localized with SUMO foci (Fig. 6g), and in the
absence of a functional SUMO-conjugating enzyme (ubc9ts) INQ
could still form (Cmr1 foci), but SUMO foci were abrogated
(Fig. 6h). Altogether, these results suggest that INQ contains
sumoylated proteins, and that Cmr1 together with Slx8 facilitate
turnover of sumoylated proteins at INQ by the proteasome,
molecular chaperones or other mechanisms.
WDR76 is the orthologue of Cmr1 in higher eukaryotes.
WDR76 is the closest orthologue of Cmr1 in higher eukaryotes
(Fig. 7a). To evaluate whether the functional characteristics of
Cmr1 are conserved in higher eukaryotes, we ﬁrst identiﬁed
WDR76 interaction partners by SILAC-based MS analysis.
Consistent with data for Cmr1, the top hits of the analysis
included subunits of the CCT/TRiC chaperonin (Fig. 7b and
Supplementary Table 4). Moreover, two chromatin-related proteins,
SUGT1 and HELLS, were identiﬁed as WDR76 interactors. In
addition, WDR76 was moderately enriched together with SUGT1
and HELLS in nascent chromatin at replication forks in a large-
scale proteomic study40, suggesting that, similar to Cmr1, WDR76
might have chromatin- and replication-associated functions.
Next we investigated the WDR76 localization using a GFP-
WDR76-expressing plasmid. WDR76 associated with chromatin
in untreated cells and relocalized into nuclear foci under
replication stress conditions (1.5mMMMS) and after proteasome
inhibition (10 mM MG132; Fig. 7c). Consistent with data from
yeast, WDR76 did not co-localize with 53BP1 foci, excluding
that WDR76 accumulates at the site of DSBs. Moreover, although
WDR76 could be detected at some PCNA replication foci, the
WDR76 foci did generally not co-localize with replication sites
(Fig. 7d), consistent with the observation that Cmr1 is not a
constitutive fork component. Taken together, these data suggest a
structural and functional conservation of Cmr1/WDR76 in
eukaryotes.
Discussion
Here we characterize a novel stress-induced structure, INQ,
which is deﬁned by perinuclear foci of Cmr1 and 27 other yeast
proteins, and induced by genotoxic stress and proteasome
inhibition. Furthermore, we provide a characterization of the
role of Cmr1 in maintenance of genome integrity. Deletion of
CMR1 causes increased chromosome loss and mutation rates, a
defect in DNA-damage checkpoint adaptation, and accumulation
of sumoylated proteins at INQ. Epistasis analyses for sensitivity to
genotoxic stress place CMR1 upstream of or in parallel to MRC1,
CTF18 and PPH3 in a recombination- and post-replicative repair-
Figure 5 | Cmr1 is involved in the response to replication stress. (a) Mrc1 and Cmr1 foci co-localize during replication stress. Co-localization between
Cmr1-YFP and Mrc1-CFP was assessed in untreated cells (IG160-4A) and after treatment with MMS for 2 h. Representative images are shown. Scale bar,
2 mm. Arrowhead indicates INQ focus. (b) Quantiﬁcation of co-localization of Mrc1 and Cmr1 in response to HU, MMS and MG132 (n4200).
(c) Checkpoint-defective Mrc1AQ protein accumulates in the nucleus. Mrc1-YFP (IG147) and Mrc1AQ-YFP (IG315) were imaged. Scale bars, 2mm.
(d) Quantiﬁcation of Mrc1AQ protein levels. Images from c were quantiﬁed (n4150). The box plot displays ﬂuorescence intensities in arbitrary units (AU),
where the line across the box identiﬁes the median sample value, the ends of the box are the 25th and 75th percentiles, and whiskers represent minimum
and maximum values. (e) Checkpoint-defective Mrc1AQ exhibits reduced recruitment to INQ. Percentage of cells with Mrc1-YFP or Mrc1AQ-YFP foci was
quantiﬁed after treatment with 0.05% MMS for 2 h. Error bars represent 95% conﬁdence intervals (n4150). (f) Mrc1 focus formation requires BTN2 and
HSP42. Mrc1-YFP localization was assessed in wild-type (IG147), btn2D (CC1–3B) and hsp42D (CC2–6B) cells. Representative images of Mrc1 localization
are shown. Scale bars, 2 mm. (g) Quantiﬁcation of Mrc1 foci in hsp42D and btn2D mutants shown in f. Error bars represent 95% conﬁdence intervals. Two
replicates, n4250. (h) Schematic representation of Mrc1 fusion to a ﬂuorescent timer. The ratio between the sfGFP (fast maturing) and mCherry (slow
maturing) ﬂuorescence intensities was calculated as a measure of Mrc1 protein turnover. (i) Quantiﬁcation of Mrc1 protein turnover. The fold difference
between the GFP and mCherry nuclear ﬂuorescence was measured in wild-type (CC98) and btn2D (CC102-9C) strains. Box plot were displayed as in d.
Two replicates, n4100. (j) CMR1 deletion suppresses the DNA damage sensitivity of checkpoint mutants. Tenfold serial dilutions were plated on YPD or
YPD containing the indicated drug. Strains were ML8–9A (wt), DP1 (cmr1D), IG156-7D (mrc1D), IG156-6C (mrc1D cmr1D), IG257-9C (pph3D), IG257-2C
(pph3D cmr1D), IG177-9C (ctf18D) and IG177-8C (ctf18D cmr1D). (k) cmr1D is synthetic sick with homologous recombination mutants. Tenfold serial
dilutions were plated on YPD or YPD containing 0.001% MMS. Strains were ML8-9A (wt), DP1 (cmr1D), IG164-1D (mre11D), IG164-2B (mre11D cmr1D),
IG162-1D (rad52D) and IG162-2D (rad52D cmr1D).
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independent pathway for genotoxic stress tolerance. Moreover,
the negative genetic interaction of cmr1D with slx8D is indicative
of a role of Cmr1 in recycling or degrading sumoylated proteins
either directly or indirectly by promoting DNA repair. The lack of
DNA damage sensitivity of the cmr1D mutant and the wild-type
levels of spontaneous Rad52 and Mec1 foci in the untreated
condition supports a more direct role of Cmr1 in promoting
the desumoylation or degradation of sumoylated proteins.
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Importantly, many of the phenotypes of cmr1D are also observed
on btn2D and/or hsp42D mutation, suggesting that shuttling
through INQ constitutes an important aspect of Cmr1 function.
However, it remains to be established whether the observed
phenotypes of the btn2D and hsp42D mutants are directly related
to a failure of INQ to form.
The genetic and physical interactions reported for Cmr1 in this
study are largely consistent with previous studies, with the
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(d) Human WDR76 does not co-localize with PCNA. Stably expressing RFP-PCNA U2OS cells were transfected with GFP-WDR76. 24 h after transfection,
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Figure 6 | Cmr1 promotes adaptation to the DNA damage checkpoint. (a) Cmr1 genetic interaction with checkpoint deactivation pathways is functionally
associated with INQ. Wild-type (ML8–9A), cmr1D (DP1), dia2D (CC4–19D), dia2D cmr1D (CC4-3B), pph3D (IG257-9C), cmr1D pph3D (IG257-2C), dia2D
pph3D (IG296-2C), cmr1D dia2D pph3D (IG296-49B), hsp42D pph3D dia2D (IG322-12A) and btn2D pph3D dia2D (IG323-19D) strains were plated.
(b) Mutants of INQ are checkpoint adaptation defective. Strains with a conditional cdc13-1mutation and otherwise wild type (ML815-8A), exo1D (DLY1296),
cmr1D (ML808-12D), rpd3D (ML807-2D), btn2D (ML821-4C) or hsp42D (ML822-4C) were examined. (c) Mutants of INQ are defective in Rad53
dephosphorylation during adaptation. cdc13-1 mutants were grown at 25 C before being shifted to the restrictive temperature of 37 C. Samples were
harvested at 0, 6 and 24h after temperature shift. Rad53 phosphorylation was detected by immunoblotting and the relative shift (Rad53P/
(Rad53þ Rad53P)) for each of the samples was quantiﬁed in the lower panel. Error bars reﬂect the s.d. of two independent experiments. (d) Negative
genetic interaction between cmr1D and slx8D. Wild-type (ML8–9A), cmr1D (DP1), slx8D (NEB290-1B) and cmr1D slx8D (IG256-5D) strains were plated.
(e) Cmr1 and Slx8 promote turnover of SUMO foci. Wild-type, cmr1D, slx8D and cmr1D slx8D cells (same strains as in d) ectopically expressing
yEmRFP-Smt3 (pML133) were imaged. Percentage of cells with Smt3 foci was quantiﬁed. Error bars represent 95% conﬁdence intervals (n4100).
(f) Sumoylated and polysumoylated proteins accumulate in the cmr1D mutant. Cells from the experiment in d were transformed with a plasmid expressing
3myc-Smt3 (pRS313-3myc-Smt3), harvested in log phase and immunoprecipitation using anti-myc-coupled dynabeads was performed on whole-cell
extracts. The temperature-sensitive ubc9-1 mutant (IG246-2C) grown at 37 C was used as a negative control. Bands corresponding to high-molecular
weight (high-MW) SUMO conjugates were quantiﬁed from two independent experiments using ImageJ. Error bars indicate s.d. (g) Co-localization of Slx8
and SUMO at INQ. Cells expressing Cmr1-CFP, Slx8-YFP and yEmRFP-Smt3 (IG302-1D transformed with pML133) were imaged. Representative image of
co-localization between Smt3 and Slx8 at INQ (Cmr1) is shown. Scale bar, 2 mm. (h) INQ contains sumoylated proteins. Cmr1 and Smt3 localization was
monitored in wild type (IG66) and ubc9ts mutant (IG246-2C) after incubation at 37 C for 2 h in the presence of 0.05% MMS. Error bars represent 95%
conﬁdence intervals (n4100).
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addition of the positive genetic interactions that we report
here11,13. With regard to other studies of nuclear foci, we
acknowledge that in addition to the 27 Cmr1-co-localizing
proteins reported here, other proteins are likely to localize to
INQ, given the limited overlap (Apc4, Tub1, Apj1, Hos2 and
Dus3) between our genome-wide screen of the GFP strain
collection using MG132 and a previous screen of the same
collection for nuclear foci induced by MMS, which identiﬁed 28
proteins13. Some of the factors that form nuclear foci after MMS
treatment are DNA repair proteins, which we show do not co-
localize with INQ. Moreover, MMS-induced Hsp104, Mkt1,
Ylr126C and Gln1 foci have been annotated as cytosolic in the
previous study13, although we ﬁnd that a subset of these foci are
in fact nuclear and co-localize with Cmr1.
Importantly, although Cmr1 and VHL foci co-localize in the
nucleus, they exhibit different genetic requirements. Although
Cmr1 foci require both BTN2 and HSP42, the relocalization of
misfolded VHL to INQ only depends on BTN2 (Supplementary
Fig. 4b). Interestingly, VHL foci can also be induced by MMS,
although less efﬁciently, and these foci are exclusively nuclear and
require both BTN2 and HSP42. These observations indicate that
the stress caused by MMS is primarily nuclear and point to
functional differences between Btn2 and Hsp42, depending on the
type of stress. In particular, being a component of INQ, Btn2 is
likely to be structurally involved in the formation of this nuclear
compartment, whereas Hsp42 might regulate the relocalization of
INQ substrates indirectly, particularly in response to replication
stress. Altogether, the differences in genetic requirements and the
variety of functions among its components deﬁne INQ as a
multifunctional compartment gathering different kinds of sub-
strates, only a proportion of which are misfolded proteins. The
possible existence of different types of Cmr1 foci is also indicated
by a subset of Cmr1 foci lacking Mrc1 (Fig. 5b). To determine the
full spectrum of biological processes involving INQ, we believe
that it will be important to examine protein relocalization to INQ
in other stress conditions such as ultraviolet irradiation, heat
shock and nutrient starvation.
As reported previously11,12, we ﬁnd that Cmr1 is a constitutive
component of chromatin and interacts with DNA replication
factors such as the MCM helicase and subunits of the replication
factor C clamp loader (Fig. 4 and Supplementary Fig. 5). We
believe these interactions to be transient, induced by replication
stress and possibly mediated by posttranslational modiﬁcations.
Moreover, given that Cmr1 has been shown to bind to DNA
in vitro12 and co-puriﬁes with histones11, it is conceivable that the
association with chromatin could be achieved by direct physical
interaction with DNA or nucleosomes, probably through the
WD40 domain. Consistently, chromatin immunoprecipitation of
Cmr1 and the replicative polymerase (Pol2) showed that Cmr1
binds chromatin independently of DNA replication (Supple-
mentary Fig. 8a–c). In line with a recent view on the regulation of
the removal and turnover of sumoylated protein complexes by
proteasome-dependent degradation pathways41, our data raise
the possibility of Cmr1 being readily available on chromatin, to
promote turnover of phosphorylated, ubiquitylated or sumoylated
targets from stalled replication forks, thereby facilitating an
efﬁcient response to replication stress (Fig. 7e). Based on our
model, this process involves INQ, in line with our establishment
of a functional relationship between the ability of Cmr1 to
accumulate at INQ and its role in genome maintenance. This
relationship does not seem to be restricted to Cmr1 as
documented by the similar accumulation of Mrc1 at INQ. In
the case of Mrc1, relocalization to INQ requires Dia2, indicating
that Mrc1 ubiquitylation is required. Consistently, we observed a
correlation between Mrc1 protein levels and its relocalization to
INQ in mrc1AQ and btn2D mutants (Fig. 5c–g), respectively,
which is consistent with the reduced Mrc1 protein turnover
observed when INQ is abolished by deletion of BTN2 (Fig. 5h,i).
As exempliﬁed by Mrc1, we hypothesize that each INQ-targeted
substrate will require speciﬁc mediators for their relocalization.
Moreover, the accumulation of proteins at INQ on inhibition or
mutation of the proteasome and/or the Slx5-Slx8 STUbL indicates
that some INQ-targeted proteins are substrates of SUMO-
dependent degradation.
Previous studies have described several classes of stress-
induced cytoplasmic foci for protein aggregation including the
JUNQ compartment and the IPOD compartment (for review see
refs 42,43). JUNQ is formed by misfolded proteins, which are
normally degraded in a manner dependent on chaperones and
the ubiquitin proteasome system20–22. In this study, we present
evidence that a JUNQ-like structure (INQ) can form in the
nucleus in response to DNA replication stress and proteasome
inhibition. This conclusion is based on several lines of evidence.
First, INQ localizes inside the nucleus, using as reference two
independent markers of the nuclear periphery, Nup49 and Hmg1,
where Hmg1 localizes continuously throughout the nuclear
envelope (Supplementary Fig. 2a). Second, 495% of nuclear
foci of misfolded VHL co-localized with Cmr1, while none of the
juxtanuclear or cytoplasmic VHL foci contain Cmr1 (Fig. 3d,e).
Third, MMS induced exclusively nuclear VHL foci, suggesting
that in response to DNA replication stress VHL is recruited to
INQ. Finally, the majority of the INQ-localized proteins are
exclusively nuclear (67%, 18/27) in the absence of stress. We
propose that the remaining proteins that do not generally localize
to the nucleus in the absence of stress might be translocated to the
nucleus speciﬁcally during stress, or that a minor nuclear pool of
these proteins could become detectable on relocalization to INQ
due to the increased local concentration.
Similar to Cmr1, its closest human orthologue WDR76
relocalizes from a diffuse nuclear distribution to distinct subnuclear
foci in response to MMS and MG132. Moreover, WDR76 interacts
with chromatin components and the CCT chaperonin. Although
we have not further investigated the nature of WDR76 foci, the
composition and properties of these structures raise the possibility
of a functional similarity between INQ in yeast and promyelocytic
leukemia (PML) nuclear bodies in higher eukaryotes. In particular,
promyelocytic leukemia nuclear bodies are induced in number and
size by genotoxic stress and proteasome inhibition44,45, they
contain both poly-sumoylated species and the RNF4 STUbL46, and
they appear to play a role in chromatin-associated processes47.
Whether WDR76 directly participates in the replication stress
response remains to be addressed.
Finally, the diverse set of proteins that localize to INQ suggests
that other biological processes may be regulated through this
structure. For example, several components of the anaphase-
promoting complex (Cdc20, Cdc27 and Apc4), which targets
substrates for proteasomal degradation during the metaphase-to-
anaphase transition (reviewed in ref. 48), localize to INQ,
suggesting that cell cycle progression during mitosis may also
require shuttling of key factors through INQ. Some INQ
localizing factors such as Gln1 and Dus3 have no reported link
to maintenance of genome integrity. However, Gln1 function is
linked to nutrient starvation and both proteins were reported to
provide resistance to osmotic stress, suggesting that different
stress responses could be coordinated at INQ or use similar
signalling mechanisms49–52. Future studies will be aimed at
dissecting the mechanisms that promote relocalization and,
possibly, turnover of individual proteins through INQ.
Methods
Yeast strains and cell culture. Standard media were used throughout this study53.
Standard genetic techniques were used to manipulate yeast strains53. Unless
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otherwise stated, yeast strains used in this study are RAD5 derivatives of W303
(Supplementary Table 5). Strains from the GFP-fusion library (Invitrogen), gene
disruption collection (Invitrogen) and VN-fusion collection (Bioneer) are
derivatives of S288C. Exceptions and mixed backgrounds are indicated.
Yeast constructs and plasmids. Construction of ﬂuorescently tagged proteins
was performed using adaptamer-mediated PCR54. To obtain the CMR1-VC::
KanMX6 construct, a PCR product containing VC-TADH1-KanMX6 was ampliﬁed
from pFA6a-VC155 (Bioneer), using Cmr1-VC155-fw and Cmr1-VC155-rv
primers adapted with overhangs, to target integration of the construct at the
C-terminal end of CMR1. The PCR product was transformed into ML659-4B,
expressing NLS-yEmRFP::HIS3 to produce IG241. To generate CMR1-YFP::
NatMX, the NatMX cassette from p4339 was ampliﬁed using Cmr1-YFP::
NatMX-fw and Cmr1-YFP::NatMX-rv primers, and the fragment targeted
downstream of CMR1-YFP terminator in IG66 to give IG188.
To generate plasmids pIG13, pIG14 and pIG15, PCR fragments containing
C-terminal YFP fusions of full-length CMR1-YFP, CMR1-NTD(1–173)-YFP or
CMR1-NLS-WD40(174–522)-YFP, respectively, including the endogenous promoter
and terminator ﬂanked by HindIII and XhoI sites, were cloned into HindIII/XhoI-
linearized pRS426. CMR1-YFP fragment was ampliﬁed from genomic DNA
extracted from IG66, using Cmr1up-F_HindIII and Cmr1down-R_XhoI primers.
CMR1-NTD(1–173) was created by fusion PCR between two fragments ampliﬁed
from pIG13. The ﬁrst fragment, including the promoter region and the NTD of
CMR1, was ampliﬁed with Cmr1-up-F_HindIII and Cmr1N-term-rv primers,
while the second fragment containing YFP and the terminator region was ampliﬁed
with Cmr1N-term-fw (harbouring the complementary sequence for annealing with
the ﬁrst fragment) and Cmr1down-R_XhoI. Fusion PCR using the two fragments
as template was performed with Cmr1upF_HindIII and Cmr1down-R_XhoI
primers. CMR1-NLS-WD40(174–522) was created with a similar approach. The ﬁrst
fragment, including the promoter region of CMR1 until the START codon, was
ampliﬁed with Cmr1up-F_HindIII and Cmr1WD40-rv (harbouring the
complementary sequence for annealing with the second fragment), while the
second fragment containing the WD40 domain fused to YFP and the terminator
region was ampliﬁed with Cmr1WD40-fw and Cmr1down-R_XhoI. Cmr1WD40-
fw contained an ATG and a sequence encoding SV40-NLS (PKKKRKVEDP).
All the subunits (Cct1 to Cct8) are essential for survival in eukaryotes and
live-cell visualization of the CCT complex had not been successful so far. We took
advantage of the crystal structure of the yeast CCT55,56, to introduce a YFP tag into
a loop of Cct6 (between position P373 and K374), which is predicted to lie on the
outer surface of the complex57. pGP564 (clone YGPM23c07) from the yeast
genomic tiling array collection (Thermo Scientiﬁc) was linearized by digestion with
BlpI, which cuts in CCT6, and gap repaired by co-transformation with a fusion
PCR fragment containing a partial sequence of CCT6 spanning over the BlpI
restriction site, with YFP inserted between P373 and K374 into strain ML8–9A.
This PCR fragment was obtained by fusion of three overlapping PCR products
generated using primers CCT6_1-fw, CCT6_2-rv, CCT6_3-fw, CCT6_4-rv,
CCT6_5-fw and CCT6_6-rv, and pGP564 and pWJ1165 as templates. The resulting
CCT6-YFP-containing plasmid was named pIG20.
The high-copy plasmid pML84, used for ectopic expression of an NLS-RFP
fusion as a nuclear marker, was constructed by ﬁrst amplifying yEmRFP from
pNEB30 using KpnI and EcoRI-adapted primers NLSyEmRFP-F and
NLSyEmRFP-R, respectively, that adds the SV40-NLS (PKKKRKVEDP) to the
N-terminal end of yEmRFP. The KpnI/EcoRI-digested PCR product was cloned
into KpnI/EcoRI-linearized pGAD-C2 behind the ADH1 promoter to generate
pML84.
The Cmr1–7Myc::KanMX6 strain was constructed by PCR-based tagging, using
primers Cmr1–13mycFW, Cmr1–13mycRV and pFA6a as template.
To construct a single-copy plasmid pML133 for expression of yEmRFP-Smt3,
yEmRFP was ﬁrst integrated into the native SMT3 locus of a diploid strain prepared
by mating IG66 and W4700-10C. The yEmRFP was integrated immediately before
the start codon of SMT3 along with the sequence 50-GGAGGTCCAGGTGGA-30
encoding a GGPGG linker using PCR-based allele replacement58. In brief, the
homology arms for targeted integration were generated from template genomic
DNA using primers Smt3-up-F, yEmRFP-Smt3-up-R, yEmRFP-Smt3start-F and
SMT3-R. Next, the two homology arms were fused by PCR to DNA sequences
containing yEmRFP joined to either the 50- or 30-end of K.l. URA3 that were PCR
ampliﬁed by primers Cherry.Fw and 30-int or 50-int and yEmRFP-R from vectors
pNEB30 and pNEB31, respectively. The two PCR fusion products were co-
transformed into yeast and transformants selected on SC-Ura. After pop-out of the
K.l. URA3 marker by selection on 5-FOA, the genomic yEmRFP-SMT3 locus was
sequenced and the diploid strain was sporulated to obtain a haploid strain ML702-
R expressing yEmRFP-Smt3. Next, the yEmRFP-Smt3 fusion was gap repaired onto
BlpI-linearized pGP564 (clone YGPM25o09) from the yeast genomic tiling array
collection (Thermo Scientiﬁc), to generate plasmid pML122. Finally, a ClaI
restriction fragment of pML122 containing the yEmRFP-SMT3 fusion was
subcloned into the ClaI site of pRS416 to produce pML133.
For construction of a strain with triple-tagged Cmr1–3YFP, we ﬁrst
assembled a fusion of either the 50- or 30-end of K.l. URA3 with a triple array
of YFP into pWJ1164 and pWJ1165, to produce plasmids pML97 and pML98,
respectively. First, YFP was PCR ampliﬁed from pWJ1164 using adapted primers
6ala-F-ClaI and XFP-R-EcoRI, digested with ClaI and EcoRI, and cloned into ClaI/
EcoRI-digested pWJ1164. Second, a EcoRI/XmaI-adapted YFP fragment generated
by PCR using primers XFP-F-EcoRI and XFP-R-XmaI, and pWJ1164 as a template,
was cloned into the EcoRI/XmaI site of this vector to produce pML97. Similarly,
YFP was PCR ampliﬁed from pWJ1165 using adapted primers XFP-F-SacI and
XFP-R-StuI-SphI-SacI, digested with SacI and cloned into SacI-linearized
pWJ1165. Second, a StuI/SphI-adapted YFP fragment generated by PCR using
primers XFP-F-StuI and XFPstop-R-SphI, and pWJ1165 as a template, was cloned
into the StuI/SphI site of this vector to produce pML98. The triple YFP (3YFP)
was integrated immediately before the stop codon of CMR1 along with a sequence
encoding a 6-alanine linker using PCR-based allele replacement58. In brief, the
homology arms for targeted integration were generated from template genomic
DNA using primers Cmr1-F, Cmr1–6ala-up, Cmr1–3xdown and Cmr1-down-R.
Next, the two homology arms were fused by PCR to DNA sequences containing
3YFP joined to either the 50- or 30-end of K.l. URA3 that were PCR ampliﬁed by
primers 6ala-F and 30-int or 50-int, and term-R from vectors pML97 and pML98,
respectively. The two PCR fusion products were co-transformed into yeast and
transformants selected on SC-Ura. After pop-out of the K.l. URA3 marker by
selection on 5-FOA, the presence of three copies of YFP was conﬁrmed by PCR.
To generate the Mrc1 timer construct, the mCherry-sfGFP::hphNT1 cassette of
pMaM60 (ref. 26) was ampliﬁed using Mrc1-S3-F and Mrc1-S2-R primers adapted
with overhangs, to target integration of the construct at the C-terminal end of
MRC1. The PCR product was transformed into ML8–9A to create CC98.
Plasmids are described in Supplementary Table 6. Oligonucleotide sequences
are listed in Supplementary Table 7.
SILAC and MS analysis. For identiﬁcation of proteins interacting with Rad52,
Rfa1 and Cmr1, S. cerevisiae cells from lysine auxotroph strains expressing Rad52-
YFP, Rfa1-YFP and Cmr1-YFP fusions, respectively, were grown in synthetic
complete medium containing lysine0 (12C6 and 14N2) or lysine8 (13C6 and 15N2;
Sigma, 608041) for more than ten generations. Cultures were treated with
200 mgml 1 zeocin (Invitrogen) for 2 h (Rad52-YFP) or 0.03% MMS (Sigma) for
2 h (Rfa1-YFP and Cmr1-YFP), and 50 optical densities per culture were harvested.
Proteins were extracted in lysis buffer without EDTA (10mM Tris-HCl pH 7.5,
150mM NaCl, 0.5% NP40, 1mM phenylmethyl sulphonyl ﬂuoride, 1 complete
protease inhibitor (Roche)) and whole-cell extracts were incubated with 25 ml of
equilibrated GFP-Trap_A beads (Chromotek) for 2 h at 4 C. Beads were washed in
50 volumes of ice-cold dilution buffer (10mM Tris-HCl pH 7.5, 150mM NaCl,
1mM phenylmethyl sulphonyl ﬂuoride, 1 complete protease inhibitor (Roche)),
before beads incubated with heavy-labelled and light-labelled proteins were mixed
and washed in 10 volumes dilution buffer. For releasing proteins from the beads,
samples containing immunoprecipitated proteins were incubated with one volume
of 4 LDS Sample Buffer (NuPAGE), 40mM dithiothreitol for 10min at 70 C
and then at room temperature for 35min. Chloroacetamide was added to a ﬁnal
concentration of 110mM and samples incubated at room temperature for 45min.
Proteins were resolved by SDS–PAGE and each loaded gel lane was sliced into
three or four slices containing an estimated equal amount of proteins. Gel pieces
were in-gel digested with trypsin protease (13 ng ml 1 trypsin in 20mM
NH4HCO3). In-gel trypsin digestion was carried out overnight at 37 C, peptides
were extracted by incubating the gel pieces with increasing concentration of
acetonitrile and collecting the resulting fractions. The organic solvent was removed
by vacuum centrifugation and peptides were reconstituted in acidiﬁed water
(containing 0.5% acetic acid). Peptides were puriﬁed with reversed-phase C18
packed StageTips59. StageTips were activated with methanol and equilibrated with
0.5% acetic acid before loading the peptides, and washed twice with 5% acetonitrile,
0.5% acetic acid. Immediately before MS analysis, peptides were eluted from
StageTips with 40ml 60% acetonitrile, 0.5% acetic acid, sample volume was reduced
toB4 ml by vacuum centrifugation and the samples were acidiﬁed with 2 ml of 0.5%
acetic acid, 1% triﬂuoroacetic acid solution. The samples were analysed by liquid
chromatography–MS/MS using the EASY-nLC HPLC (Thermo Scientiﬁc) and
quadrupole Orbitrap mass spectrometers (LTQ-Orbitrap Velos or Q-Exactive,
Thermo Scientiﬁc). Samples were loaded on 15-cm long reversed-phase columns
(diameter 75mm, packed with 3 mm size C18-AQ material (ReproSil-Pur,
Dr Maisch). Peptides were separated by using a linear gradient of acetonitrile (from
5% to 40%) and 0.5% acetic acid. Mass spectrometers were operated in a positive
ion mode, data-dependent manner, automatically switching between MS and MS2
acquisition. The survey full scan was set up to scan m/z¼ 300–1,700 for the Velos
mass spectrometer and m/z¼ 300–1,750 for the Q Exactive mass spectrometer,
with resolutions of 30,000 and 70,000 for the Velos and Q Exactive, respectively.
The top 10 or 12 most intense ions were sequentially isolated and fragmented by
higher-energy C-trap dissociation. An ion selection threshold of 5,000 was used.
Peptides with unassigned charge states, as well as with charge state oþ 2 were
excluded from fragmentation. A dynamic exclusion window of 30 s was used to
limit re-sequencing. Fragment spectra were acquired in the Orbitrap mass analyser.
MS raw data ﬁles were analysed with the MaxQuant software package (developer’s
version 1.2.2.9)60,61. Full-scan peaks and fragment-scan peaks were searched
against the Saccharomyces Genome Database release 63 containing 6,717 putative
protein sequences (http://downloads.yeastgenome.org/). Standard settings were
used for the software, except that ‘Minimum Ratio Count’ was set to 1. Cysteine
carbamidomethylation was searched as a ﬁxed modiﬁcation, whereas protein
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N-terminal acetylation and methionine oxidation were searched as variable
modiﬁcations. Database search was performed with a mass tolerance of 6 p.p.m. for
precursor ions and 20 p.p.m. for fragment ions. False discovery rate was estimated
using a target-decoy approach, allowing a maximum of 1% false identiﬁcations
from the reversed-sequence database.
For determining WDR76 interactome, HeLa cells were cultured in DMEM
medium supplemented with 10% fetal bovine serum, L-glutamine, penicillin and
streptomycin. For SILAC labelling, cells were cultured in media containing either
84mgml 1 L-arginine and 146mgml 1 L-lysine or 84mgml 1 L-arginine-U-13C6-
15N4 and 146 mgml 1 L-lysine-U-13C6-15N2 (Cambridge Isotope Laboratories) for
B14 days62. Cells were transfected with pcDNA-DEST53-GFP-WDR76 or empty
vector and lysed in modiﬁed RIPA buffer (50mM Tris-HCl pH 7.5, 150mM NaCl,
1% NP-40, 0.1% Na-deoxycholate, 1mM EDTA and protease inhibitors 5mM
b-glycerophosphate, 5mM NaF, 1mM Na-orthovanadate, complete protease
inhibitor cocktail (Roche)) after 48 h. Lysates were cleared by centrifugation at
17,000g for 15min at 4 C, and GFP-WDR76 and its interacting proteins were
enriched using GFP-Trap resin (ChromoTek) for 2 h. Proteins were resolved by
SDS–PAGE and digested in-gel with trypsin. Peptide fractions were analysed on a
quadrupole Orbitrap mass spectrometer (Q-Exactive, Thermo Scientiﬁc) equipped
with a nanoﬂow HPLC system (Thermo Scientiﬁc)63. Raw data ﬁles were analysed
using MaxQuant software (version 1.2.2.9)60,61.
Synthetic genetic array. SGA technology64 was used to transfer the CMR1-VC::
KanMX6 and the CMR1-YFP::NatMX NLS-yEmRFP::URA3 constructs from the
query strains (IG241 and IG189-10B, respectively) to each of the VN fusion library
(Bioneer) and gene deletion collection (Invitrogen) strains, respectively. For
analysis of CMR1 genetic interactions, SGA analysis was performed in
quadruplicates (1,536 format). MATa meiotic progeny derived from the
cmr1::NatMX query strain (IG105) or the control strain (SG936) were tested for
viability on YPD plates containing 200mM HU. Plates were scanned (ScanMaker
9800XL, Microtek) and growth differences between the tester and control plates
were quantiﬁed using ScreenMill29.
Yeast live-cell imaging and immunoﬂuorescence. For live-cell imaging, cells
were grown at 25 C in synthetic complete or the appropriate dropout medium
supplemented with adenine (100 mgml 1), unless otherwise stated. For detection
of untagged Cmr1 by immunoﬂuorescence, ﬁxed cells were incubated with anti-
Cmr1 primary antibody (kind gift of Sung-Ho Bae)12, followed by staining with
Alexa Fluor 594-conjugated anti-rabbit secondary antibody at 1:1,000 dilution
(Invitrogen, catalogue number A11037). DNA was stained by adding 10 mgml 1
DAPI (40 ,6-diamidino-2-phenylindole). Fluorophores were visualized on a
DeltaVision Elite microscope (Applied Precision, Inc.). For statistics, at least 100
morphologically intact cells were examined. Fluorescence intensities were
measured with Volocity software (PerkinElmer) and presented as box plots using
Prism software (GraphPad Software, Inc.).
For high-throughput ﬂuorescence microscopy, cells were grown in 96-well
plates in synthetic complete medium supplemented with adenine (100 mgml 1)
and diluted 20-fold before imaging in 384-well CellCarrier plates (PerkinElmer).
Drug treatment was performed manually or by automated dispensing. Imaging was
performed on an Opera QEHS high-content screening microscope (PerkinElmer).
For the GFP co-localization screen, stacked images of ﬁve ﬁelds per well were
acquired. One second exposure time for each channel was used. For the Cmr1-YFP
screens, ten ﬁelds per well were acquired. One second exposure time was used. Data
analysis was performed using Columbus software (PerkinElmer).
Microscopy of human cells. Cells were pre-extracted with 0.5% Triton in CSK
buffer (10mM PIPES pH 7, 100mM NaCl, 300mM sucrose, 3mM MgCl2) for
5min at 4 C before ﬁxation or ﬁxed directly with 4% formaldehyde. The cells
were blocked with 5% BSA in PBS-T, incubated with primary antibody, washed
three times with PBS-T, incubated with secondary antibody and washed again.
DNA was counterstained with DAPI and slides were mounted using Vectashield
anti-fade (Vector)65. Primary antibodies against 53BP1 (NB100–904, Novus) at
1:200 dilution and secondary Alexa Fluor-coupled antibodies (A11037, Invitrogen)
at 1:1,000 dilution were commercial. U2OS cells stably expressing RFP-PCNA were
described66. Images were collected using a DeltaVision system.
DNA damage sensitivity. For analysis of drug sensitivity on solid medium,
tenfold serial dilutions were prepared from a saturated overnight culture. Zeocin
(Invitrogen), MMS (Sigma), HU (Sigma), 4-nitroquinoline-1-oxide (Sigma) and
camptothecin (Sigma) were added to the ﬁnal concentrations stated in the ﬁgure
legends. After spotting, the plates were incubated at 30 C for 2–4 days.
Protein analysis. For detection of Cmr1 protein levels, whole-cell extracts were
obtained by TCA extraction. Frozen cell pellets were resuspended in 20% TCA and
beaten with glass beads. Beads were washed twice in 5% TCA and the washes
combined with the lysed cell mix to yield a ﬁnal concentration of 10% TCA.
The cell extract was centrifuged, the pellet resuspended in Laemmli buffer and
neutralized with 1M Tris-base solution. Samples were boiled, centrifuged and the
supernatant loaded on polyacrylamide gels. Rabbit anti-Cmr1 (1:250, clone 2.1,
Cambridge Research Biochemicals) followed by horseradish peroxidase-conjugated
swine anti-rabbit antibody (1:5,000, P0399, Dako) was used for detecting
Cmr1-TAP. Tubulin was detected using rat anti-tubulin (1:5,000, ab6160, abcam)
followed by horseradish peroxidase-conjugated rabbit anti-rat (1:5,000, P0450,
Dako). For detection of sumoylated proteins, cells expressing 3myc-Smt3 were
harvested in log phase and proteins were extracted by bead beating in extraction
buffer (10mM Tris-HCl pH 7.5, 0.5% NP-40, 150mM NaCl). N-ethylmaleimide
(50mM) was added during the extraction and immunoprecipitation, to stabilize
SUMO-conjugates. For immunoprecipitation, monoclonal anti-Myc antibody
(9E10, Santa Cruz Biotechnology, catalogue number sc-40) was incubated
with whole-cell extracts before coupling with equilibrated Dynabeads. Rad53
phosphorylation was detected using an anti-Rad53 antibody (Abcam, catalogue
number ab104232) at 1:2,000 dilution. Uncropped immunoblots are shown in
Supplementary Fig. 9.
Chromosome loss and mutation rates. The rate of spontaneous mutation at
CAN1 resulting in canavanine resistance (CanR) was determined by plating
overnight stationary cultures onto synthetic complete medium lacking arginine
and supplemented with L-canavanine (50 mgml 1). To calculate the rate of
spontaneous frameshift mutations at the lys2::InsA14 locus, cells were plated on
synthetic complete medium lacking lysine67. Five to twenty-one single cultures
were analysed for each strain and the median frequency was used to determine the
mutation rate68. To determine the replication stress-induced mutation frequencies,
overnight cultures were diluted and exposed to MMS before plating.
Rates of loss of the mating-type (MAT) locus on chromosome III were
determined as a measure of chromosome loss by the bimaters assay. Overnight
cultures of wild-type or homozygous mutant diploid strains were appropriately
diluted, plated onto complete medium and grown for 1–2 days. Cells were
subsequently tested for the ability to mate with a MATa tester strain (R113) and
mating events deriving from the loss of the MATa loci were counted. Three to
seventeen trials were analysed and the s.d. was used to compare the different
mutants.
Checkpoint adaptation assay. The cdc13-1mutation was introduced into relevant
mutant strains by genetic crossing. To measure checkpoint adaptation34, cells were
grown shaking in YPD to mid-log phase, shifted to 32 C for 2 h, sonicated, diluted
appropriately and spread onto preheated YPD plates at 32 C. After incubation of
the plates at 32 C for 24 h, images were acquired of 200–300 microcolonies and the
number of cell bodies in each colony counted.
Statistical methods. For microscopy experiments, the signiﬁcance of the
differences observed between different cell populations was determined by
one-tailed Fisher’s exact test. P-values with Po0.05 were considered signiﬁcant.
The 95% conﬁdence interval for the median of a population was used to compare
mutation rates.
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